|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 39/395 | (2006.01) |
| C07K 16/28 | (2006.01) | ||
| C07K 16/32 | (2006.01) |
| (11) | Number of the document | 1549344 |
| (13) | Kind of document | T |
| (96) | European patent application number | 03757931.5 |
| Date of filing the European patent application | 2003-10-09 | |
| (97) | Date of publication of the European application | 2005-07-06 |
| (45) | Date of publication and mention of the grant of the patent | 2015-01-07 |
| (46) | Date of publication of the claims translation | 2015-04-27 |
| (86) | Number | PCT/EP2003/011164 |
| Date | 2003-10-09 |
| (87) | Number | WO 2004/032960 |
| Date | 2004-04-22 |
| (30) | Number | Date | Country code |
| 02022390 | 2002-10-10 | EP | |
| 02022389 | 2002-10-10 | EP |
| (72) |
KREYSCH, Hans-Georg, DE
SCHMIDT, Jürgen, DE
|
| (73) |
Merck Patent GmbH,
Frankfurter Strasse 250, 64293 Darmstadt,
DE
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Farmacinės kompozicijos, nukreiptos į ERB-B1 receptorius |
| PHARMACEUTICAL COMPOSITIONS DIRECTED TO ERB-B1 RECEPTORS |
| Payment date | Validity (years) | Amount | |
| 2015-09-22 | 13 | 289.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2016-10-09 |